These are five stocks for aggressive investors looking to get share count leverage on companies that have sizable upside potential. While not suited for all investors, they are not penny stocks with absolutely no track record or liquidity.
ETF Managers Group LLC increased its position in shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT – Get Rating) by 308.9% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 172,386 shares of the company’s stock after acquiring an additional 130,225 shares during the period. ETF Managers […]
ETF Managers Group LLC raised its stake in Adaptive Biotechnologies Co. (NASDAQ:ADPT – Get Rating) by 308.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 172,386 shares of the company’s stock after purchasing an additional 130,225 shares during the quarter. ETF […]
Adaptive Biotechnologies (NASDAQ:ADPT – Get Rating) and Krystal Biotech (NASDAQ:KRYS – Get Rating) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, dividends, earnings and risk. Volatility & Risk Adaptive Biotechnologies has a beta of 1.18, […]